JP Morgan Chase’s Tenaya Therapeutics TNYA Stock Holding History
Bought
Maintained
Sold
Other funds holding TNYA
VCM
EAM
BGM
KCM
JP Morgan Chase's TNYA Position: Q1 2026 in Review
JP Morgan Chase increased its Tenaya Therapeutics (TNYA) stake by 30% in Q1 2026, buying an estimated $3.04K and bringing the position to 17,950 shares worth $11.1K. The position accounts for ﹤0.01% of the portfolio, ranked #6711.
JP Morgan Chase first reported a position in TNYA in Q3 2021 and has held it in 18 quarters since. The position peaked at $7.37M in Q4 2024. 103 funds tracked by Wall St. Rank hold TNYA as of Q1 2026.
- JP Morgan Chase held 17,950 shares of Tenaya Therapeutics worth $11.1K as of Q1 2026.
- JP Morgan Chase bought 4,123 Tenaya Therapeutics shares in Q1 2026, an estimated $3.04K.
- Tenaya Therapeutics made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #6711 holding.
- JP Morgan Chase first reported a position in Tenaya Therapeutics in Q3 2021 and has held it in 18 quarters since.
- JP Morgan Chase's Tenaya Therapeutics position peaked at $7.37M in Q4 2024.
- 103 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2026.
Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.